Emile Calenda1, Olivier Genevois2, Annie Cardon1, Marc Muraine2. 1. Department of Anesthesia, Rouen University Hospital, 1 rue de Germont, Rouen cedex 76031, France. 2. Department of Ophthalmology, Rouen University Hospital, 1 rue de Germont, Rouen cedex 76031, France.
Abstract
AIM: To check the safety of continuation of oral anticoagulants in ophthalmic procedures requiring a peribulbar anesthesia. METHOD: A prospective case control study included 750 patients with oral anticoagulants in group A and 750 patients who had never been treated with oral anticoagulant in group B. Hemorrhages were graded as follows: 1) spot ecchymosis of eyelid and or subconjunctival hemorrhage; 2) eyelid ecchymosis involving half of the lid surface area; 3) eyelid ecchymosis all around the eye, no increase in intraocular pressure; 4) retrobulbar hemorrhage with increased intraocular pressure. RESULTS: In group A, grade 1 was observed in 13 patients (1.74%) and grade 2 in 2 patients (0.26%). In group B, grade 1 was observed in 12 patients (1.6%) and grade 2 was absent. No 3 or 4 hemorrhage grade was encountered in both groups. There was not significant difference in grade 1 hemorrhage between both groups (P=0.21). CONCLUSION: Oral anticoagulants were not associated with a significant increase in potentially sight-threatening local anesthetic complications.
AIM: To check the safety of continuation of oral anticoagulants in ophthalmic procedures requiring a peribulbar anesthesia. METHOD: A prospective case control study included 750 patients with oral anticoagulants in group A and 750 patients who had never been treated with oral anticoagulant in group B. Hemorrhages were graded as follows: 1) spot ecchymosis of eyelid and or subconjunctival hemorrhage; 2) eyelid ecchymosis involving half of the lid surface area; 3) eyelid ecchymosis all around the eye, no increase in intraocular pressure; 4) retrobulbar hemorrhage with increased intraocular pressure. RESULTS: In group A, grade 1 was observed in 13 patients (1.74%) and grade 2 in 2 patients (0.26%). In group B, grade 1 was observed in 12 patients (1.6%) and grade 2 was absent. No 3 or 4 hemorrhage grade was encountered in both groups. There was not significant difference in grade 1 hemorrhage between both groups (P=0.21). CONCLUSION: Oral anticoagulants were not associated with a significant increase in potentially sight-threatening local anesthetic complications.
Authors: A C Spyropoulos; A G G Turpie; A S Dunn; J Spandorfer; J Douketis; A Jacobson; F J Frost Journal: J Thromb Haemost Date: 2006-06 Impact factor: 5.824
Authors: Robert D McBane; Waldemar E Wysokinski; Paul R Daniels; Scott C Litin; Joshua Slusser; David O Hodge; Nicole F Dowling; John A Heit Journal: Arterioscler Thromb Vasc Biol Date: 2010-02-05 Impact factor: 8.311
Authors: J D Benzimra; R L Johnston; P Jaycock; P H Galloway; G Lambert; A K K Chung; T Eke; J M Sparrow Journal: Eye (Lond) Date: 2008-02-08 Impact factor: 3.775
Authors: Oliver Zeitz; Laura Wernecke; Nicolas Feltgen; Christoph Sucker; Jürgen Koscielny; Thomas Dörner Journal: Ophthalmologe Date: 2021-07-19 Impact factor: 1.059
Authors: Augusto Takaschima; Patricia Marchioro; Thiago M Sakae; André L Porporatti; Luis André Mezzomo; Graziela De Luca Canto Journal: PLoS One Date: 2016-01-22 Impact factor: 3.240